Analyst consensus rating
Achieve Life Sciences Analyst Rating: Strong Buy
Direct answer
Achieve Life Sciences's consensus rating is Strong Buy.
13 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $14.15.
Forecast evidence checked November 3, 2026.
Get free Achieve Life Sciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $6.61
- Average price target
- $14.15
- High price target
- $21.00
- Low price target
- $9.00
- Low target gap
- +36.2%
- Target upside
- +114.1%
- High target gap
- +217.7%
- Target range width
- 181.5%
- Consensus rating
- Strong Buy
- Analysts
- 13
- Evidence date
- November 3, 2026
- Valid through
- November 10, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Achieve Life Sciences?
Achieve Life Sciences has a verified Strong Buy consensus. The same dataset has an average price target of $14.15.
How far are Achieve Life Sciences's low and high targets from the recorded price?
The low target implies +36.2%, while the high target implies +217.7%.
How many analysts are included in Achieve Life Sciences's consensus?
The verified consensus includes 13 analysts.
How is Achieve Life Sciences's target upside or downside calculated?
The average target of $14.15 is divided by the recorded price of $6.61, then one is subtracted to produce +114.1%. This does not guarantee a future return.
When was Achieve Life Sciences's analyst forecast verified?
The data was verified on 2026-11-03. The dataset is valid through 2026-11-10.